Raymond James Financial Inc Xencor Inc Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Xencor Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 42,280 shares of XNCR stock, worth $390,667. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,280
Previous 101,346
58.28%
Holding current value
$390,667
Previous $2.33 Million
80.71%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XNCR
# of Institutions
206Shares Held
78.6MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$103 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$90.2 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$73 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$56.8 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$36.3 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $552M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...